Use of angiotensin-converting enzyme inhibitors as monotherapy and in combination with diuretics and calcium channel blockers .
Angiotensin-converting enzyme ( ACE ) inhibitors have earned an important place in medical therapy since their discovery about two decades ago .
This family of drug has grown tremendously since the introduction of captopril in 1981. .
There are currently more than 14 ACE inhibitors in the world and 9 are available in the United States .
Although these agents share many similarities , they differ in their pharmacokinetic properties , approved indications , and cost .
This paper provides guidance for selection of ACE inhibitors by examining the pharmacokinetics , pharmacodynamics , drug interactions , adverse effects , and cost of these agents .
Combination products of ACE inhibitors with either diuretics or calcium channel blockers also are reviewed .
